COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 19: Line 19:
*Mounika Vadiyala
*Mounika Vadiyala
*Sara Haddadi
*Sara Haddadi
 
*Sara Zand


'''Dermatologic Disorders of COVID-19 Team Members'''
'''Dermatologic Disorders of COVID-19 Team Members'''
*Nuha Shah
*Nuha Shah
*Hannah Abude
*Hannah Abude


'''Frequently Asked Inpatient Questions Team Members'''
'''Frequently Asked Inpatient Questions Team Members'''
* [[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
* [[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]   
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]   
* [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]]
* [[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
'''Frequently Asked Outpatient Questions Team Members'''
'''Frequently Asked Outpatient Questions Team Members'''
* [[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]]
* [[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]]
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]]
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]]


'''Hematologic disorders of COVID-19 Team Members'''
'''Hematologic disorders of COVID-19 Team Members'''


'''Nephrologic Disorders of COVID-19 Team Members'''
'''Nephrologic Disorders of COVID-19 Team Members'''
Line 44: Line 41:
*[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
*[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]]
*Nasrin Nikravan
*Nasrin Nikravan


'''Neurologic Disorders and COVID-19 Team Members'''
'''Neurologic Disorders and COVID-19 Team Members'''
Line 51: Line 47:
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
*[[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]]
*[[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]]


'''Ongoing Clinical Trials of COVID-19 Team Members'''
'''Ongoing Clinical Trials of COVID-19 Team Members'''


* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
* <br />
<br />
'''Pulmonary Disorders and COVID-19 Team Members'''
'''Pulmonary Disorders and COVID-19 Team Members'''


*Rana Aljebzi
*Rana Aljebzi
Line 65: Line 60:
<br />  
<br />  
'''Other Team Members'''
'''Other Team Members'''
*Oluwabusola Adogba
*Oluwabusola Adogba
*[[User:Rija Gul|Rija Gul, M.D.]]
*[[User:Rija Gul|Rija Gul, M.D.]]
*Sara Zand
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]
*Zaida Obeidat
*Zaida Obeidat

Revision as of 12:40, 11 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

  • Nuha Shah
  • Hannah Abude

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pulmonary Disorders and COVID-19 Team Members

  • Rana Aljebzi
  • Ayesha Farheen Javid

Radiologic Manifestations of COVID-19 Team Members
Other Team Members